Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients
Creator
Mandourah, Yasser
Abudayah, Abdullah
Aldaghestani, Tareef
Alghamedi, Adnan
Alwan, Abid
Hassan, Sahar
Mustafa, Mohamed
Sakr, Yasser
Talag, Ali
Omrani, Ali
Albarrak, Mohammed
Almekhlafi, Ghaleb
Malik, Muhammad
Source
Medline; PMC
abstract
BACKGROUND: Middle East respiratory syndrome coronavirus infection is associated with high mortality rates but limited clinical data have been reported. We describe the clinical features and outcomes of patients admitted to an intensive care unit (ICU) with Middle East respiratory syndrome coronavirus (MERS-CoV) infection. METHODS: Retrospective analysis of data from all adult (>18 years old) patients admitted to our 20-bed mixed ICU with Middle East respiratory syndrome coronavirus infection between October 1, 2012 and May 31, 2014. Diagnosis was confirmed in all patients using real-time reverse transcription polymerase chain reaction on respiratory samples. RESULTS: During the observation period, 31 patients were admitted with MERS-CoV infection (mean age 59 ± 20 years, 22 [71 %] males). Cough and tachypnea were reported in all patients; 22 (77.4 %) patients had bilateral pulmonary infiltrates. Invasive mechanical ventilation was applied in 27 (87.1 %) and vasopressor therapy in 25 (80.6 %) patients during the intensive care unit stay. Twenty-three (74.2 %) patients died in the ICU. Nonsurvivors were older, had greater APACHE II and SOFA scores on admission, and were more likely to have received invasive mechanical ventilation and vasopressor therapy. After adjustment for the severity of illness and the degree of organ dysfunction, the need for vasopressors was an independent risk factor for death in the ICU (odds ratio = 18.33, 95 % confidence interval: 1.11–302.1, P = 0.04). CONCLUSIONS: MERS-CoV infection requiring admission to the ICU is associated with high morbidity and mortality. The need for vasopressor therapy is the main risk factor for death in these patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-016-1303-8) contains supplementary material, which is available to authorized users.
has issue date
2016-05-07
(
xsd:dateTime
)
bibo:doi
10.1186/s13054-016-1303-8
bibo:pmid
27153800
has license
cc-by
sha1sum (hex)
53d4dd6acd3501c47b364dbae1ba3dd2083b895a
schema:url
https://doi.org/10.1186/s13054-016-1303-8
resource representing a document's title
Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients
has PubMed Central identifier
PMC4859954
has PubMed identifier
27153800
schema:publication
Crit Care
resource representing a document's body
covid:53d4dd6acd3501c47b364dbae1ba3dd2083b895a#body_text
is
schema:about
of
named entity 'data'
named entity 'tachypnea'
named entity 'infection'
named entity 'real-time'
named entity 'After'
named entity 'ICU'
named entity 'samples'
named entity 'Middle East respiratory syndrome'
named entity 'Invasive'
named entity 'OUTCOME'
named entity 'USING'
named entity 'RATIO'
named entity 'CONFIRMED'
named entity 'SCORES'
named entity 'BILATERAL PULMONARY INFILTRATES'
named entity '2880'
named entity 'PATIENTS'
named entity 'INTENSIVE CARE UNIT'
named entity 'OUR'
named entity 'RESPIRATORY SAMPLES'
named entity 'VASOPRESSOR'
named entity 'THESE'
named entity 'APPLIED'
named entity 'ADJUSTMENT'
named entity 'MIXED'
named entity 'SOFA'
named entity 'DATA'
named entity 'TACHYPNEA'
named entity 'ASSOCIATED WITH'
named entity 'DEGREE'
named entity 'ADULT'
named entity 'MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS'
named entity 'BACKGROUND'
named entity 'APACHE II'
named entity 'RISK FACTOR'
named entity 'LIMITED'
named entity 'DIAGNOSIS'
named entity 'THERAPY'
named entity 'TWENTY-THREE'
named entity 'CONCLUSIONS'
named entity 'OCTOBER'
named entity 'MORBIDITY AND MORTALITY'
named entity 'HIGH'
named entity 'OLD'
named entity '0.04'
named entity 'REPORTED'
named entity 'OBSERVATION'
named entity 'NEED FOR'
named entity 'INFECTION'
named entity 'ICU'
named entity 'CLINICAL FEATURES'
named entity 'AGE'
named entity 'INTENSIVE CARE UNIT STAY'
named entity 'BUT'
named entity 'OUTCOMES'
named entity 'ADMISSION'
named entity 'SAUDI'
named entity 'INTENSIVE CARE UNIT'
named entity 'PRESENTATION'
named entity 'PATIENTS'
named entity 'MIDDLE EAST RESPIRATORY SYNDROME '
named entity 'REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION'
named entity 'COUGH'
named entity 'VASOPRESSORS'
named entity 'RETROSPECTIVE ANALYSIS'
named entity '2887'
named entity 'DEATH'
named entity 'METHODS'
named entity 'GREATER'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 7
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software